Get the Stockscreener App
22.47
0.76%
+0.17
Landos Biopharma Inc Stock (LABP) Forecast
The Landos Biopharma Inc (LABP) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $21.65, representing a -3.65% decrease from the current price of $22.47. The highest analyst price target is $24.67, and the lowest is $18.64.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LABP Price Target
Average 20.33
(-9.55% Downside)
Is Landos Biopharma Inc (LABP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 77.65 | Sell |
| STOCH(9,6) | 63.69 | Neutral |
| STOCHRSI(14) | 16.50 | Buy |
| MACD(12,26) | 0.881 | Sell |
| ADX(14) | 74.01 | Buy |
| William %R | -16.42 | Sell |
| CCI(14) | 128.26 | Buy |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
22.29
Buy
|
22.31
Buy
|
| MA20 |
22.28
Buy
|
21.91
Buy
|
| MA50 |
18.59
Buy
|
18.67
Buy
|
| MA100 |
11.85
Buy
|
14.29
Buy
|
| MA200 |
7.8796
Buy
|
9.8446
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, LABP could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 3 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on LABP, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 77.65 indicates that LABP is overbought. This suggests that LABP price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 63.69 indicates that LABP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 16.5 indicates that LABP is oversold. This suggests that LABP price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 74.01 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 128.26 indicates that LABP is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term LABP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Landos Biopharma Inc financial reports and earnings history, Landos Biopharma Inc (LABP) stock could reach $26.24 by 2030, $60.87 by 2040 and $133.67 by 2050. See the projected annual prices until 2050 of the Landos Biopharma Inc stock below:
- Landos Biopharma Inc (LABP) is expected to reach an average price of $51.43 in 2035, with a high prediction of $51.61 and a low estimate of $49.96. This indicates an $128.87% rise from the last recorded price of $22.47.
- Landos Biopharma Inc (LABP) stock is projected to chart a bullish course in 2040, with an average price target of $59.64, representing an $165.43% surge from its current level. The forecast ranges from a conservative $59.46 to a sky-high $60.87.
- Our analysts predict Landos Biopharma Inc (LABP) to jump 261.59% by 2045, soaring from $80.61 to an average price of $81.25, potentially reaching $81.27. While $80.61 is the low estimate, the potential upside is significant.
- Landos Biopharma Inc (LABP) stock is expected to climb by 2050, reaching an average of $133.37, a $493.55% jump from its current level. However, a wide range of estimates exists, with high and low targets of $133.67 and $131.80, respectively, highlighting the market's uncertainty.
Landos Biopharma Inc Stock (LABP) Year by Year Forecast
Landos Biopharma Inc Stock (LABP) Price Forecast for 2024
Our forecast for LABP stock price in 2024 now indicates an average price target of $15.07 with a high forecast of $26.39 and a low forecast of $3.75. The average prediction reflects an decrease of -32.94% from the last recorded price of $22.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $19.17 | $18.64 | $24.67 | -14.71% |
| July, 2024 | $20.73 | $18.42 | $21.84 | -7.75% |
| August, 2024 | $20.83 | $19.80 | $22.44 | -7.31% |
| September, 2024 | $21.99 | $20.46 | $22.78 | -2.16% |
| October, 2024 | $21.20 | $19.62 | $22.03 | -5.66% |
| November, 2024 | $24.01 | $20.61 | $24.20 | +6.84% |
| December, 2024 | $24.82 | $23.21 | $25.96 | +10.48% |
Landos Biopharma Inc Stock (LABP) Price Forecast for 2025
Landos Biopharma Inc Stock (LABP) is expected to reach an average price of $19.55 in 2025, with a high prediction of $26.67 and a low estimate of $12.42. This indicates an -13.00% fall from the last recorded price of $22.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $25.13 | $23.85 | $26.67 | +11.83% |
| February, 2025 | $25.16 | $23.91 | $25.94 | +11.96% |
| March, 2025 | $18.11 | $17.66 | $25.82 | -19.38% |
| April, 2025 | $15.86 | $15.53 | $18.38 | -29.43% |
| May, 2025 | $14.44 | $13.98 | $16.43 | -35.75% |
| June, 2025 | $13.35 | $13.25 | $14.94 | -40.57% |
| July, 2025 | $13.25 | $12.88 | $13.60 | -41.04% |
| August, 2025 | $12.99 | $12.94 | $13.50 | -42.21% |
| September, 2025 | $12.56 | $12.48 | $13.03 | -44.09% |
| October, 2025 | $12.74 | $12.42 | $12.74 | -43.31% |
| November, 2025 | $12.82 | $12.67 | $13.04 | -42.93% |
| December, 2025 | $13.06 | $12.82 | $13.17 | -41.87% |
Landos Biopharma Inc Stock (LABP) Price Forecast for 2026
The predicted value for Landos Biopharma Inc (LABP) in 2026 is set at an average of $15.67. Estimates vary from a peak of $18.28 to a trough of $13.05, indicating an -30.28% surge from the present price of $22.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $13.26 | $13.05 | $13.71 | -41.00% |
| February, 2026 | $13.44 | $13.14 | $13.70 | -40.17% |
| March, 2026 | $13.33 | $13.21 | $13.55 | -40.66% |
| April, 2026 | $13.13 | $13.06 | $13.48 | -41.58% |
| May, 2026 | $13.24 | $13.11 | $13.24 | -41.07% |
| June, 2026 | $13.63 | $13.25 | $13.72 | -39.32% |
| July, 2026 | $13.73 | $13.53 | $13.79 | -38.91% |
| August, 2026 | $13.81 | $13.73 | $13.86 | -38.56% |
| September, 2026 | $13.88 | $13.82 | $13.95 | -38.21% |
| October, 2026 | $14.06 | $13.90 | $14.08 | -37.43% |
| November, 2026 | $14.19 | $14.07 | $14.20 | -36.84% |
| December, 2026 | $18.01 | $14.22 | $18.28 | -19.86% |
Landos Biopharma Inc Stock (LABP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Landos Biopharma Inc (LABP) is $28.00, with a high forecast of $38.67 and a low forecast of $17.34. This indicates an +24.63% increase from the last price of $22.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $18.29 | $17.34 | $18.66 | -18.62% |
| February, 2027 | $18.32 | $18.04 | $18.64 | -18.45% |
| March, 2027 | $18.35 | $17.78 | $18.83 | -18.35% |
| April, 2027 | $18.54 | $17.89 | $18.82 | -17.51% |
| May, 2027 | $18.66 | $17.94 | $18.67 | -16.94% |
| June, 2027 | $19.72 | $18.13 | $19.77 | -12.25% |
| July, 2027 | $19.41 | $18.82 | $19.67 | -13.64% |
| August, 2027 | $19.60 | $18.35 | $19.74 | -12.78% |
| September, 2027 | $20.60 | $19.43 | $21.04 | -8.33% |
| October, 2027 | $21.91 | $20.28 | $22.11 | -2.51% |
| November, 2027 | $37.17 | $21.19 | $37.56 | +65.44% |
| December, 2027 | $38.17 | $37.16 | $38.67 | +69.86% |
Landos Biopharma Inc Stock (LABP) Price Forecast for 2028
In 2028, Landos Biopharma Inc (LABP) is projected to reach an average price of $32.44, with a high projection of $38.36 and a low estimate of $26.52. This indicates an +44.37% rise from the last price of $22.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $32.20 | $31.40 | $38.36 | +43.32% |
| February, 2028 | $29.46 | $29.33 | $35.78 | +31.11% |
| March, 2028 | $29.53 | $28.03 | $30.98 | +31.41% |
| April, 2028 | $31.68 | $29.48 | $32.25 | +41.01% |
| May, 2028 | $31.97 | $29.75 | $32.73 | +42.28% |
| June, 2028 | $30.20 | $29.75 | $32.05 | +34.39% |
| July, 2028 | $33.99 | $29.92 | $34.05 | +51.29% |
| August, 2028 | $35.26 | $32.90 | $36.40 | +56.92% |
| September, 2028 | $36.24 | $34.69 | $37.18 | +61.27% |
| October, 2028 | $34.88 | $34.46 | $36.95 | +55.24% |
| November, 2028 | $29.00 | $28.55 | $36.63 | +29.06% |
| December, 2028 | $27.54 | $26.52 | $29.30 | +22.55% |
Landos Biopharma Inc Stock (LABP) Price Forecast for 2029
The 2029 price forecast for Landos Biopharma Inc Stock (LABP) is $25.94 on average, with a high prediction of $27.64 and a low estimate of $24.24. This represents an +15.44% increase from the previous price of $22.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $25.63 | $25.17 | $27.64 | +14.07% |
| February, 2029 | $24.69 | $24.55 | $26.20 | +9.88% |
| March, 2029 | $24.42 | $24.36 | $25.04 | +8.66% |
| April, 2029 | $24.72 | $24.51 | $25.07 | +10.02% |
| May, 2029 | $24.35 | $24.27 | $24.84 | +8.36% |
| June, 2029 | $24.57 | $24.24 | $24.62 | +9.35% |
| July, 2029 | $24.73 | $24.59 | $25.07 | +10.07% |
| August, 2029 | $25.34 | $24.87 | $25.41 | +12.76% |
| September, 2029 | $25.66 | $25.29 | $26.05 | +14.21% |
| October, 2029 | $25.99 | $25.58 | $26.24 | +15.66% |
| November, 2029 | $26.02 | $25.82 | $26.13 | +15.79% |
| December, 2029 | $25.96 | $25.82 | $26.19 | +15.53% |
Landos Biopharma Inc Stock (LABP) Price Forecast for 2030
Landos Biopharma Inc Stock (LABP) is expected to reach an average price of $29.69 in 2030, with a high forecast of $33.44 and a low forecast of $25.93. This signifies an +32.11% surge from the last price of $22.47.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $26.24 | $25.93 | $26.24 | +16.76% |
| February, 2030 | $26.77 | $26.28 | $26.86 | +19.13% |
| March, 2030 | $26.98 | $26.70 | $26.99 | +20.05% |
| April, 2030 | $27.20 | $27.02 | $27.21 | +21.05% |
| May, 2030 | $27.43 | $27.22 | $27.50 | +22.05% |
| June, 2030 | $27.73 | $27.47 | $27.74 | +23.43% |
| July, 2030 | $28.09 | $27.79 | $28.10 | +25.00% |
| August, 2030 | $32.16 | $28.15 | $32.27 | +43.11% |
| September, 2030 | $32.41 | $31.47 | $32.83 | +44.25% |
| October, 2030 | $32.67 | $32.22 | $32.99 | +45.39% |
| November, 2030 | $32.58 | $32.27 | $33.20 | +44.98% |
| December, 2030 | $33.09 | $32.34 | $33.44 | +47.28% |
0.77%
1.20%
Cap:
|
Volume (24h):